Stitt W Z, Scott G A, Martin R E, Gaspari A A
Department of Dermatology, University of Rochester School of Medicine and Dentistry, NY, USA.
Am J Contact Dermat. 1996 Sep;7(3):166-70.
Chronic actinic dermatitis represents a spectrum of photosensitive dermatoses. Phototesting and photopatch testing are necessary to elucidate the specific subtype. Such patients may have multiple cutaneous allergies and photoallergies.
This is a case report of a patient with chronic actinic dermatitis whose condition was worsened by certain sunscreens and corticosteroids. Our purpose was to identify the specific subtype of chronic actinic dermatitis and cutaneous allergens.
Phototesting to UVB and UVA was performed. Photopatch testings to standard photoallergens and to Photoplex sunscreen ingredients was performed. Patch testing to standard allergens and proprietary corticosteroids was performed.
Positive photoallergies to Photoplex sunscreen and the UVA screen within Photoplex, Parsol 1789 (4-tert-butyl-4'-methoxydibenzoyl-methane), were identified. Positive allergies to Aclovate (alclometasone dipropionate) cream and ointment and Locoid (hydrocortisone butyrate) ointment were identified. The patient showed increased UVB sensitivity.
This is a case report of a patient with chronic actinic dermatitis. A relevant photoallergy to Parsol 1789 and corticosteroid sensitivities to aclometasone and hydrocortisone butyrate were identified. Multiple cutaneous allergens may be identified in patients with chronic actinic dermatoses, and avoidance of known allergens may result in significant improvement of the chronic dermatitis.
慢性光化性皮炎代表一系列光敏性皮肤病。光试验和光斑贴试验对于明确特定亚型是必要的。此类患者可能有多种皮肤过敏和光过敏反应。
这是一例慢性光化性皮炎患者的病例报告,其病情因某些防晒霜和皮质类固醇而加重。我们的目的是确定慢性光化性皮炎的特定亚型和皮肤过敏原。
对紫外线B(UVB)和紫外线A(UVA)进行光试验。对标准光变应原和Photoplex防晒霜成分进行光斑贴试验。对标准变应原和专利皮质类固醇进行斑贴试验。
确定对Photoplex防晒霜以及Photoplex中的UVA防晒剂帕索1789(4-叔丁基-4'-甲氧基二苯甲酰甲烷)存在阳性光过敏反应。确定对艾洛松(二丙酸倍氯米松)乳膏和软膏以及乐肤液(丁酸氢化可的松)软膏存在阳性过敏反应。该患者显示出紫外线B敏感性增加。
这是一例慢性光化性皮炎患者的病例报告。确定了对帕索1789的相关光过敏反应以及对二丙酸倍氯米松和丁酸氢化可的松的皮质类固醇敏感性。慢性光化性皮肤病患者可能会发现多种皮肤过敏原,避免已知过敏原可能会使慢性皮炎显著改善。